Vishnu Suresh Babu, PhD

Title(s)Postdoctoral Scholar, Medicine
SchoolSchool of Medicine
AddressLocation Required
Phone415-476-0158
ORCID ORCID Icon0000-0001-8104-8652 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Maastricht University, NetherlandsPhD07/2021Ocular Oncology
    University of Sheffield, United KingdomMS03/2013Stem cell and Regenerative Medicine
    Vinayaka Missions University, IndiaBE05/2011Biotechnology & Genetic Engineering

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a. Cancers (Basel). 2022 Oct 19; 14(20). Suresh Babu V, Bisht A, Mallipatna A, Sa D, Dudeja G, Kannan R, Shetty R, Guha N, Heymans S, Ghosh A. PMID: 36291907; PMCID: PMC9600213.
      View in: PubMed   Mentions:
    2. Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels. Cells. 2022 Oct 11; 11(20). Suresh Babu V, Dudeja G, Sa D, Bisht A, Shetty R, Heymans S, Guha N, Ghosh A. PMID: 36291051; PMCID: PMC9600484.
      View in: PubMed   Mentions:
    3. Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors. Cells. 2022 05 18; 11(10). Babu VS, Mallipatna A, Sa D, Dudeja G, Kannan R, Shetty R, Nair AP, Gundimeda S, Chaurasia SS, Verma NK, Lakshminarayanan R, Heymans S, Barathi VA, Guha N, Ghosh A. PMID: 35626705; PMCID: PMC9139581.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Retinoblastoma genetics screening and clinical management. BMC Med Genomics. 2021 07 22; 14(1):188. Gupta H, Malaichamy S, Mallipatna A, Murugan S, Jeyabalan N, Suresh Babu V, Ghosh A, Ghosh A, Santhosh S, Seshagiri S, Ramprasad VL, Kumaramanickavel G. PMID: 34294096; PMCID: PMC8296631.
      View in: PubMed   Mentions: 1     Fields:    
    Vishnu's Networks
    Concepts (17)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _